Dashboard
Manage Tickers

STTKShattuck Labs, Inc.

Nasdaq shattucklabs.com


$ 6.19 $ -0.65 (-9.5 %)    

Friday, 14-Jun-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 6.19
$ 6.53
$ 0.00 x 0
$ 0.00 x 0
$ 6.14 - $ 6.61
$ 1.33 - $ 11.76
510,703
na
313.01M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-15-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-10-2021 03-31-2021 10-Q
14 03-16-2021 12-31-2020 10-K
15 11-13-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

assessing-shattuck-labs-insights-from-6-financial-analysts
Assessing Shattuck Labs: Insights From 6 F...
06/14/2024 16:00:16

needham-maintains-buy-on-shattuck-labs-lowers-price-target-to-8
Needham Maintains Buy on Shattuck Labs, Lo...
06/14/2024 15:51:22

Needham analyst Gil Blum maintains Shattuck Labs (NASDAQ:STTK) with a Buy and lowers the price target from $12 to $8.

shattuck-labs-discloses-updated-interim-data-from-phase-1b-dose-expansion-clinical-trial-of-sl-172154-in-combination-with-azacitidine-in-frontline-higher-risk-myelodysplastic-syndromes-and-tp53-mutant-acute-myeloid-leukemia-patients
Shattuck Labs, Discloses Updated Interim D...
06/14/2024 10:16:34

The company observed 67% Objective Response Rate (ORR) in frontline HR-MDS patients, primarily with TP53 mutations; initial com...

shattuck-labs-granted-orphan-drug-designation-by-fda-for-sl-172154-in-acute-myeloid-leukemia
Shattuck Labs Granted Orphan Drug Designat...
06/10/2024 11:37:04

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
05/15/2024 15:49:50

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

shattuck-labs-to-present-additional-data-from-phase-1b-dose-expansion-trial-of-sl-172154-trial-at-eha-2024-congress-jun-14
Shattuck Labs To Present Additional Data F...
05/14/2024 20:25:48

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
05/14/2024 17:11:49

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
05/03/2024 10:23:43

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
05/02/2024 17:15:17

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

shattuck-labs-cash-and-cash-equivalents-and-investments-of-1146m-for-the-quarter-ended-march-31-2024--will-be-sufficient-to-fund-its-operations-into-2026
Shattuck Labs Cash And Cash Equivalents An...
05/02/2024 12:14:41

shattuck-labs-q1-2024-gaap-eps-037-beats-046-estimate-sales-1115m-beat-228500k-estimate
Shattuck Labs Q1 2024 GAAP EPS $(0.37) Bea...
05/02/2024 12:11:40

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.46)...

shattuck-labs-reports-preclinical-data-demonstrating-therapeutic-utility-of-trim7-inhibition-to-prevent-or-reverse-acquired-resistance-to-immune-checkpoint-therapy
Shattuck Labs Reports Preclinical Data Dem...
04/09/2024 20:15:33

These data were featured in an oral presentation during the AACR Annual Meeting 2024, being held from April 5-10, 2024, in San ...

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
04/09/2024 10:18:08

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
03/01/2024 12:46:56

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
03/01/2024 11:53:15

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

shattuck-labs-q4-eps-041-beats-057-estimate
Shattuck Labs Q4 EPS $(0.41) Beats $(0.57)...
02/29/2024 21:23:57

Shattuck Labs (NASDAQ:STTK) reported quarterly losses of $(0.41) per share which beat the analyst consensus estimate of $(0.57)...

hc-wainwright--co-reiterates-buy-on-shattuck-labs-maintains-28-price-target
HC Wainwright & Co. Reiterates Buy on Shat...
02/13/2024 17:33:14

HC Wainwright & Co. analyst Joseph Pantginis reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $28 price t...

needham-reiterates-buy-on-shattuck-labs-maintains-12-price-target
Needham Reiterates Buy on Shattuck Labs, M...
02/13/2024 14:38:13

Needham analyst Gil Blum reiterates Shattuck Labs (NASDAQ:STTK) with a Buy and maintains $12 price target.

shattuck-labs-announces-drug-discovery-collaboration-with-ono-pharmaceutical-for-bifunctional-fusion-proteins-targeting-certain-autoimmune-and-inflammatory-disease-pathways-shattuck-to-receive-upfront-and-be-eligible-for-milestone-payments-of-upto-227m
Shattuck Labs Announces Drug Discovery Col...
02/13/2024 11:04:09

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
01/19/2024 21:31:09

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)